Agade, acronym for Anti-Gravity Active Device for Exoskeletons, is our robotic technology patented in 2019.

Born from a research project of Politecnico di Milano University on the development of exoskeletons to assist people affected by muscular dystrophy in daily life activities.

Lorenzo Aquilante

Co-founder & CEO

Sofia Paganelli

Co-founder & Lead Firmware Eng.

Daniele Ramirez

Co-founder & COO

Mattia Tabaglio

Co-founder & CTO

Innovation and improvement

We believe in empowering people through technology. Our mission is to transform the way of working, with a focus on people’s well-being and health through innovative and intelligent human-tailored robotics.

Our story

2017

Beginning of project research at the Politecnico di Milano

2018

Agade project wins the PoliMi competition Switch2Product

2019

Agade’s technology is patented and its first lab prototype developed

2020

Agade’s incorporation and closing of investment round with 360 Capital Partners and Genera Imprese

2021

The European Innovation Council selects Agade to access up to 8.3M€ of funding

2022

Tests on field of Agadexo Shoulder Beta with Brembo, CLO, and other pilot clients

2023

Agade closes a €4M investment round with Cysero, 360 CP, EIC Fund, CDP VC, Brembo, and Genera Imprese.

2024

Agade launches its first product on the market: the exoskeleton Agadexo Shoulder.

HUMAN-TAILORED ROBOTICS

Find out more

Join our team

We believe that our success is driven by the extraordinary people who work with us. We are always looking for new talent and if you want to be part of our team, send us your application.

Join us